Stocks of FibroGen Inc (NASDAQ:FGEN) traded higher last session on Wall Street, up 7.48% to $1.58.
FGEN stock price is now -20.95% away from the 50-day moving average and -8.22% away from the 200-day moving average. The market capitalization of the company currently stands at $156.06M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $4 to $2, BofA Securities Downgraded its rating from Neutral to Underperform for FibroGen Inc (NASDAQ: FGEN). , while ‘Stifel’ rates the stock as ‘Hold’
In other news, Wettig Thane, CEO bought 50,000 shares of the company’s stock on Mar 07 ’24. The stock was bought for $95,470 at an average price of $1.91. Upon completion of the transaction, the CEO now directly owns 470,178 shares in the company, valued at $0.74 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 01 ’23, Director Henderson Jeffrey William sold 2,000 shares of the business’s stock. A total of $2,060 was realized by selling the stock at an average price of $1.03. This leaves the insider owning 28,866 shares of the company worth $45608.28. A total of 7.02% of the company’s stock is owned by insiders.
During the past 12 months, FibroGen Inc has had a low of $0.33 and a high of $20.90. The fifty day moving average price for FGEN is $1.9987 and a two-hundred day moving average price translates $1.7215 for the stock.
The latest earnings results from FibroGen Inc (NASDAQ: FGEN) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at -$0.57, missing analysts’ expectations of -$0.42 by -0.15. This compares to -$0.70 EPS in the same period last year. The net profit margin was -192.37% and return on equity was -42790.17% for FGEN. The company reported revenue of $27.14 million for the quarter, compared to $34.37 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -21.03 percent. For the current quarter, analysts expect FGEN to generate $36.67M in revenue.
